First Time Loading...
O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 6.2 EUR 10.52%
Updated: May 21, 2024

Wall Street
Price Targets

OPTOMED Price Targets Summary
Optomed Oyj

Wall Street analysts forecast OPTOMED stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPTOMED is 6.03 EUR with a low forecast of 5.05 EUR and a high forecast of 7.88 EUR.

Lowest
Price Target
5.05 EUR
19% Downside
Average
Price Target
6.03 EUR
3% Downside
Highest
Price Target
7.88 EUR
27% Upside
Optomed Oyj Competitors:
Price Targets
0TN
Bioretec Oy
16% Upside
SBS
Stratec SE
1% Downside
688271
Shanghai United Imaging Healthcare Co Ltd
24% Upside
SRT
Sartorius AG
67% Upside
PODD
Insulet Corp
30% Upside
DXR
Daxor Corp
145% Upside
2160
Microport Cardioflow Medtech Corp
118% Upside
6869
Sysmex Corp
19% Upside

Revenue
Forecast

Revenue Estimate
Optomed Oyj

For the last 4 years the compound annual growth rate for Optomed Oyj's revenue is 0%. The projected CAGR for the next 3 years is 37%.

0%
Past Growth
37%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Optomed Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat

Net Income
Forecast

Net Income Estimate
Optomed Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPTOMED's stock price target?
Price Target
6.03 EUR

According to Wall Street analysts, the average 1-year price target for OPTOMED is 6.03 EUR with a low forecast of 5.05 EUR and a high forecast of 7.88 EUR.

What is Optomed Oyj's Revenue forecast?
Projected CAGR
37%

For the last 4 years the compound annual growth rate for Optomed Oyj's revenue is 0%. The projected CAGR for the next 3 years is 37%.